{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-082071","form_type":"8-K","ticker":null,"cik":"0001796129","company_name":"Vincerx Pharma, Inc.","filed_at":"2024-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.561032+00:00","generated_at":"2026-06-04T05:29:56.820816+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vincerx Pharma enters $50M ATM equity offering agreement with Leerink Partners","bullets":["Up to $50M of common stock may be sold at-the-market through Leerink Partners as agent.","Commission of 3.0% of gross proceeds payable to Leerink; no obligation to sell any shares.","Sales occur under existing S-3 shelf registration (filed Jan 2022, effective Jan 2022).","Company may suspend or terminate sales at any time; either party may terminate the agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-082071","json":"https://secwatch.observer/filing/0001193125-24-082071.json","markdown":"https://secwatch.observer/filing/0001193125-24-082071.md","text":"https://secwatch.observer/filing/0001193125-24-082071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796129/000119312524082071/0001193125-24-082071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796129/000119312524082071/d819653d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T05:29:56.820816+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2737c4a575899454788dcc4dbd3ec39951e72bc6","claim":"Vincerx Pharma, Inc. entered into Sales Agreement with Leerink Partners LLC valued at up to $50,000,000 (effective 2024-03-29).","evidence_excerpt":"On March 29, 2024, Vincerx Pharma, Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with Leerink Partners LLC (the “Sales Agent”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1796129/000119312524082071/0001193125-24-082071-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Leerink Partners LLC"},{"label":"Value","value":"up to $50,000,000"},{"label":"Effective","value":"2024-03-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}